A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer
Verschraegen, Claire F, Gupta, Elora, Loyer, Evelyne, Kavanagh, John J, Kudelka, Andrzej P, Freedman, Ralph S, Edwards, Creighton L, Harris, Nick, Steger, Melissa, Steltz, Veronica, Giovanella, BeppinVolume:
10
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199904000-00005
Date:
April, 1999
File:
PDF, 709 KB
1999